Cadence Neuroscience, Inc. — Form D
Cadence Neuroscience, Inc. of SAMMAMISH, WA, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-28. The offering totals $26.0M, of which $26.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-02-28
- Form: D
- Accession: 0001712390-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $26.0M
- Amount sold: $26.0M
- Investors: 7
- Date of first sale: 2023-02-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-474511
Issuer
- Name: Cadence Neuroscience, Inc.
- CIK: 0001712390
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 2036 223RD PLACE NE, SAMMAMISH, WA, 98074
- Phone: 425-681-6863
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Gerry Douglas Brunk | Director | Sammamish, WA |
| Kevin Douglas Chu | Director | Sammamish, WA |
| John Douglas Harris | Director | Sammamish, WA |
| Kent Leyde | Director | Sammamish, WA |
| Kent Leyde | Executive Officer | Sammamish, WA |
| Warren Douglas Sheffield | Executive Officer | Sammamish, WA |
| Kent Leyde | Promoter | Sammamish, WA |
| Warren Douglas Sheffield | Director | Sammamish, WA |
| Warren Douglas Sheffield | Promoter | Sammamish, WA |
| Andrew Douglas Firlik | Director | Sammamish, WA |
Other filings by this issuer (2)
More